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• Mitigation policy has a beneficial effect in reducing greenhouse gas
(GHG) emissions, because it introduces cleaner fuels and improves
energy efficiency. These mitigation measures also reduce emissions of
air pollutants such as oxides of nitrogen (NOx), sulphur dioxide (SO2)
and fine particles (PM), and as a result, they improve air quality.
• Despite large improvements in Europe in recent decades, current air
quality (air pollution) levels are responsible for adverse health and
environmental impacts, including a significant shortening of life
expectancy. These impacts have large economic costs. The air quality
improvements from mitigation policy will reduce these costs, and
therefore lead to economic co-benefits.
• These ancillary co-benefits are important when comparing the costs
and benefits of mitigation. Whilst the full benefit of European GHG
reductions may only be experienced by future generations and occur at
the global level, the ancillary benefits of air quality improvements occur
in the short-term and lead to direct (local) benefits in Europe.
• The ClimateCost study has assessed the health, environmental and
economic air quality benefits of mitigation policy. The analysis used the
GAINS and ALPHA models to assess a mitigation policy scenario that is
consistent with the EC’s 2 degrees target, and compared this to a
baseline medium-high emissions scenario.
• The estimated benefits of the 2 degrees stabilisation (mitigation)
scenario, over and above the baseline scenario, are substantial.
• Under the mitigation scenario, there are large reductions in EU air
pollutant emissions, with a 60% reduction in sulphur dioxide (SO2) and
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a 46% reduction in oxides of nitrogen (NOx) when
compared to the baseline in 2050. There is also a 19%
reduction in emissions of particulate matter (PM).
• These emission reductions – and the associated
improvement in air quality – lead to large health benefits.
Under the mitigation scenario, average life expectancy in
Europe (EU27) is extended by 1 month of life by 2050:
equivalent to an annual benefit of 480,000 years of life.
• In addition, the mitigation scenario reduces the number of
ozone related deaths in the EU27 by 3400 fatalities a year
by 2050, as well as reducing the annual number of cases
of chronic bronchitis and hospital admissions by 27,000
and 20,000 respectively. It also leads to an estimated
reduction of 127 million minor symptom days each year by
2050.
• The economic benefits of these health improvements are
estimated at €43 billion per year in 2050 in the EU27
(current prices, undiscounted), based on a value of life
years lost approach for the change in mortality risk. Using
an alternative valuation metric of the value of a statistical
life, the benefits of the mitigation scenario increase to
€94 billion per year by 2050.
• When expressed against the CO2 reductions achieved, the
air quality co-benefits of the mitigation scenario are around
€24 for each tonne of CO2 reduced over the period
investigated.
• GHG mitigation policies also reduce the need to
implement air quality pollution measures and equipment
required by legislation. These avoided costs have also
been considered in ClimateCost, using the GAINS model.
Under the mitigation scenario, the regulatory air quality
costs in the EU27 are reduced by €36 billion per year by
2050, mostly due to avoided costs of NOx and PM control
in the transport sector.
• The mitigation scenario also leads to important co-benefits
for managed and unmanaged ecosystems, reducing
acidification and eutrophication. Under the mitigation
scenario, the area of forest in the EU27 that exceeds the
critical loads for acid deposition is reduced by 42
thousand km2 by 2050, a 15% reduction on the baseline.
The area of ecosystems in the EU27 that exceeds the
critical load for nitrogen deposition and eutrophication is
reduced by 144 thousand km2 by 2050.
• The study has also considered the air quality benefits of
global mitigation policy in other world regions using the
GAINS model, which reveals even larger health benefits.
Under the mitigation scenario, the average life expectancy
gain is estimated at 19 months in China and nearly 30
months in India by 2050, compared to the baseline, and
would also reduce ozone related mortality by more than 75
thousand cases per year across the two countries.
• The magnitude of the co-benefits above demonstrates
they are very relevant to the policy discussion on the costs
and benefits of mitigation. It also emphasises the
importance of exploiting synergies in the fields of climate
and air pollution.
1. Introduction
The objective of the ClimateCost project is to advance
knowledge on the economics of climate change, focusing on
three key areas: the economic costs of climate change (the
costs of inaction), the costs and benefits of adaptation, and
the costs and benefits of long-term targets and mitigation.
The project has assessed the impacts and economic costs
of climate change in Europe and globally. This included a
bottom-up sectoral impact assessment and analysis of
adaptation for Europe, as well as a global economic
modelling analysis with sector-based impact models,
computable general equilibrium models and global economic
integrated assessment models.
This technical policy briefing note (TPBN)1 provides an
overview of the air quality benefits work undertaken in the
project, which has assessed the avoided impacts and
economic ancillary benefits of mitigation policy, focusing on
Europe (EU27), though with discussion of the benefits for
China and India. The paper is based on ClimateCost reports
by Rafaj et al (2011) and Holland et al (2011a)2.
1.1 Background
Air pollution has a number of important impacts on human
health, as well as on the natural and man-made
environment. These include impacts of short-term and long-
term exposure to air pollution on our health, damage to
building materials, effects on crops, and impacts on natural
and semi-natural ecosystems (both terrestrial and aquatic).
These are described in the box below. These impacts have a
number of important economic costs – known as external
costs or externalities – as they are not included in the price
of goods or services that lead to air pollution.
Concerns over these impacts have led to the introduction of
major air quality policies in Europe over the past few
decades. These were initially driven by the need to reduce
impacts on natural or semi-natural ecosystems (acidification
and eutrophication) and were implemented as international
agreements to reduce emissions. More recently, they have
focused on reducing the significant impacts of air quality
concentrations on human health and the wider environment.
These have been translated through to a set of policies,
which includes the Thematic Strategy on Air Pollution (CEC,
2005). These policies have led to substantial reductions in
emissions – and improvement of air quality – since the late
1970s.
Nevertheless, air pollution still leads to widespread health
and environmental impacts in Europe. Recent reports for the
European Commission (Amann et al, 2011; Holland et al,
2011b) estimate that across Europe as a whole, as far east
as the European regions of Russia, nearly 5 million life years
will be lost annually as a result of emissions in 2020, and
37% of ecosystems will be at risk of damage from nitrogen
deposition.
At the same time that air pollution policy continues to target
these impacts, it has become apparent that mitigation policy
can lead to very large reductions in the air pollutant
emissions – and thus large improvements in air quality.
These arise because the use of cleaner fuels (e.g.
renewables) or reduced demand (e.g. through energy
efficiency) reduces fossil fuel use and the associated
combustion emissions of oxides of nitrogen (NOx), sulphur
dioxide (SO2) and fine particles (PM). These provide
additional benefits that should be considered when weighing
up the potential costs and benefits of mitigation policy
directed at GHG control.
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1 The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007- 2013) under grant agreement
n° 212774. This TPBN was written by Mike Holland and Alistair Hunt from Metroeconomica, Markus Amman, Chris Heyes, Peter Rafaj and Wolfgang Schöpp
from the Mitigation of Air Pollution & Greenhouse Gases (MAG) Program of IIASA, and Paul Watkiss from Paul Watkiss Associates (UK). The citation should be:
Holland, M., Amann, M., Heyes, C., Rafaj, P., Schöpp, W. Hunt, A., and Watkiss, P. (2011). (2011). The Reduction in Air Quality Impacts and Associated
Economic Benefits of Mitigation Policy. Summary of Results from the EC RTD ClimateCost Project. In Watkiss, P (Editor), 2011. The ClimateCost Project. Final
Report. Volume 1: Europe. Published by the Stockholm Environment Institute, Sweden, 2011. ISBN 978-91-86125-35-6.
2 This note is a summary of two ClimateCost reports, from Work Package 5.1.
– Co-benefits of post-2012 global GHG-mitigation policies. Peter Rafaj, Wolfgang Schöpp, Peter Russ‡, Chris Heyes, Markus Amann. Mitigation of Air Pollution
& Greenhouse Gases (MAG) Program, IIASA. ‡Institute for Prospective Technological Studies (IPTS), Joint Research Centre (JRC), Seville, Spain.
– Quantification and monetisation of the co-benefits from control of regional air pollutants. Mike Holland, Alistair Hunt, Fintan Hurley, Brian Miller, Anne Wagner,
Ritu Mathur, Atul K, Anil Ramaprasad.
These are summarised in the final deliverable, which is available from the ClimateCost website.
These ancillary air quality benefits are different to the benefits
of mitigation in reducing global climate change. While the
benefit of GHG reductions from mitigation are mostly
experienced by future generations at the global level, the
ancillary air quality benefits accrue to the current generation
and are local or regional in nature. They therefore provide
immediate and tangible benefits to those who reduce GHG
emissions.
Mitigation policy therefore has potential to generate large co-
benefits for Europe. Moreover, there are potentially even
greater benefits for other major emitters, notably in major
developing countries which have much higher baseline levels
of air pollution, such as China and India. These countries are
increasingly suffering air quality pollution levels that are
similar to historic European levels, with the health and
environmental impacts. Reducing GHG emissions in these
countries will thus produce large, immediate and localised
benefits, and provide an extra justification for a low carbon
transition.
Against this background, the ClimateCost project has
quantified the benefits of mitigation policy, in terms of
physical impacts and the monetary values. This technical
briefing note summarises the approach and findings.
2. Socio-Economic
Projections and Scenarios
In the assessment of the future effects of mitigation policy,
assumptions have to be made about future conditions,
which require socio-economic scenarios. In scientific terms,
a scenario is a plausible future (‘storyline’) of environmental
and anthropogenic change as informed by expert
Air Quality
The impacts of air pollution
Studies of early air pollution episodes (such as the London
smog episodes of the 1950s) revealed that very high levels
of ambient air pollution are associated with strong increases
in health impacts. Recent studies also reveal smaller
increases at the current levels of air pollution typical of
Europe. The health effects associated with short-term (acute)
exposure include premature mortality (deaths brought
forward), respiratory and cardio-vascular hospital
admissions, and probably exacerbation of asthma and other
respiratory symptoms. The evidence for these effects is
strongest for particulates (usually characterized as PM10 or
PM2.5) and for ozone. There is also now strong evidence that
long-term (chronic) exposure to particulates damages health
and that these effects, measured through reduced life
expectancy, are substantially greater than the effects of
acute exposure. These health impacts have major economic
costs because of the additional burden they impose on the
health service, the lost time at work, and the pain and
suffering of affected individuals.
Air pollution also impacts on other receptors. The effects of
atmospheric pollutants on buildings provide some of the
clearest examples of air pollution damage. Air pollution is
associated with a number of impacts including acid
corrosion of stone, metals and paints in ‘utilitarian’
applications; acid impacts on materials of cultural merit
(including stone, fine art, etc.); ozone damage to polymeric
materials, particularly natural rubbers; and soiling of
buildings. SO2 is the primary pollutant of concern in building
corrosion. The analysis of building soiling is concerned with
the deposition of particles on external surfaces and the dis-
colouration of stone and other materials.
Ozone is recognised as the most serious regional air
pollutant problem for agriculture in Europe at the present
time, though some air pollutants other than ozone have been
linked in the literature to crop damages (e.g. SO2, NO2, HF),
though generally at higher levels than are currently
experienced.
Air pollution also impacts on natural and semi-natural
ecosystems. The effects of SO2 and secondary pollutants
on ecosystems ranging from forests to freshwaters are well
known, and have been the prime concern until recently in
international negotiations. Emissions of NOX are also known
to be responsible for a range of impacts on ecosystems
particularly through their contribution to acidification,
eutrophication and the generation of tropospheric ozone.
Recent analysis shows that the problem of eutrophication
from N deposition is far more extensive than current
problems from acidification.
judgement, but it does not mean that this future will
necessarily occur.
The most widely used in the context of climate change are
the emissions scenarios of the IPCC Special Report on
Emission Scenarios (the SRES scenarios, Nakicenovic et al.,
2000). These define a set of future self-consistent and
harmonised socio-economic conditions and emissions
futures that, in turn, have been used to assess potential
changes in climate through the use of global and regional
climate models. There is a wide range of future drivers and
emissions paths associated with the scenarios.
The ClimateCost project focused on a number of scenarios.
This included consideration of SRES medium-high (A1B) and
a mitigation scenario consistent with the EU 2 degree target,
based on ENSEMBLES E1 scenario (van der Linden et al.,
2009).
In the analysis of air quality co-benefits reported in this
technical briefing note, a slightly updated set of emission
scenarios has been used, based on projections of energy
use data provided by the POLES model (Russ et al, 2009).
These include consideration of current air quality legislation.
They are broadly consistent with the SRES A1B and
ENSEMBLES E1 scenarios, but with some minor
differences, notably in the emission profile in recent years
and in the immediate future. These updated scenarios are
particularly important here because of the greater analytical
focus on the short-term and on local impacts (in Europe), i.e.
to ensure the analysis matches a current profile consistent
with current emissions and air quality concentrations.
2.1 Scenarios used
The Baseline scenario used in this analysis explores a
baseline situation in which no further climate and air pollution
policies are implemented beyond that in place in the year
2010, thus energy consumption from 2010 through to 2050
is driven by population and economic growth. Note that this
does take into account the existence of the emission trading
scheme (ETS) market in the EU and the prospect of future
climate policies in other countries. It also includes the
consequences of the financial crisis in 2008/2009, and the
evolution of the oil prices, but it excludes the implementation
of the unilateral GHG reduction target (20% compared to
1990 by 2020) and the renewables target (20% by 2020) as
proposed in the EU energy and climate change package
(EC, 2008).
The Mitigation scenario used in this analysis was provided
by the POLES model. It is a greenhouse gas reduction
scenario with global CO2 emissions reduced by 60% in 2050
compared to 1990. These reductions, together with those in
agriculture and in land-use change and forestry (de-
forestation), contribute to achieving a global mean
temperature increase of less than 2 degrees above pre-
industrial levels. The scenario assumes developed countries
take on a collective emission reduction target and set up a
trading system such as the EU ETS or similar policy
measures that establish a carbon price for the energy
intensive industrial sectors, including the power sector.
Energy intensive sectors in developing countries are
exposed to a low carbon price, simulating the limited
penetration or visibility of a carbon price for all individual
firms through policy instruments such as the CDM.
Further details of both scenarios are available from Rafaj et al
(2011).
The project has assessed these two scenarios, reported as
the baseline and the 2 degrees target, and has assessed the
difference between them to provide the economic benefits of
mitigation. The assessment has been undertaken for the
future decades from today through to 2050. It is stressed
that benefits would continue to accrue beyond this time so
long as policies remained in place.
3. Methods
The usual approach taken for the detailed quantification of
the benefits of air pollution emissions through to
monetisation is often referred to as the ‘impact pathway
approach’. This is a logical progression from emissions,
through the estimation of the modelled dispersion and
change in air quality concentrations, to exposure and
quantification of impacts and their valuation. This approach
was advanced through the series of EC Research projects
under the ExternE series (EC, 1995, 1999).
The approach is shown in Figure 1 below.
ClimateCost has used this impact pathway approach
through the following series of steps:
1. Quantification of emissions;
2. Analysis of pollutant dispersion and chemistry across
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Europe (and also China and India) and assessment of the
change in air pollution concentrations;
3. Quantification of the exposure of people, environment
and buildings that are affected by air pollution, i.e. linking
pollution with the ‘stock at risk’ e.g. using population
data;
4. Quantification of the impacts of air pollution, using
relationships from studies that link pollution
concentrations with physical impacts such as crop
damages or health impacts;
5. Valuation of the impacts. This is undertaken from the
perspective of ‘willingness to pay’ (WTP). For some
effects, such as damage to crops, this approach can be
carried out using market data. For non-market effects
such as on health, the assessment uses a combination
of the ‘market’ data (e.g. the cost of medicines and care)
combined with estimates of people’s willingness to pay
from stated and revealed preference techniques.
The analysis used two models to undertake this analysis,
working within a Geographical Information Systems (GIS)
framework: the GAINS (Greenhouse Gas and Air Pollution
Interactions and Synergies) model and the ALPHA model.
Both are described in the box below.
The two models are complementary as they focus on
different aspects of the steps in Figure 1 above. Both the
GAINS model (SERI, 2004, also 2007, 2009)3 and the CAFE
CBA method (Krupnick et al, 2004) have been extensively
peer reviewed, and applied previously in EC policy impact
assessment (CEC, 2005b).
Air Quality
3 See http://gains.iiasa.ac.at/index.php/documentation-of-model-methodology/model-reviews/gains-review-2009.
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Figure 1. Impact Pathway Approach
Source: Watkiss et al, 2008.
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4 http://www.ec4macs.eu/home/index.html?sb=1.
Greenhouse Gas and Air
Pollution Interactions and
Synergies – GAINS
The Greenhouse and Air pollution Interactions and Synergies
(GAINS) model explores cost-effective strategies to reduce
emissions of greenhouse gases (GHG) and conventional air
pollutants. The GAINS model (http://gains.iiasa.ac.at)
produces emission scenarios for all major air pollutants for
any exogenously supplied projection of future economic
activities, abatement potentials, and costs as well as
interactions in abatement between various pollutants
(Amman et al., 2011).
It includes detailed atmospheric chemistry and transport
models which allow the atmospheric modelling of emissions
and the estimation of pollution concentrations, including
both primary and secondary pollutants. These
concentrations are combined with other necessary data
such as critical loads and levels, relative risk factors,
population, ecosystems areas, etc. This then allows the
estimation of the effects on human health from the exposure
of fine particles and ground-level ozone, and the ecosystems
damage to vegetation via excess deposition of acidifying and
eutrophying compounds.
The model also has a detailed abatement module which
allows the analysis of abatement control to reduce these
impacts, using a cost-effectiveness framework that can
address multiple targets of health and ecosystem protection,
as well as reducing GHG emissions. Thereby, GAINS allows
for a comprehensive and combined analysis of air pollution
and climate change mitigation strategies, which reveals
important synergies and trade-offs between these policy
areas.
Within the ClimateCost study the global version of GAINS
was run to estimate the air pollution changes associated
with the emission reduction scenarios, and the associated
benefits to ecosystems and health.
CAFE CBA and the ALPHA
model
The Atmospheric Long-range Pollution Health/environment
Assessment (ALPHA) model (Holland et al, 2008) was
developed to provide a detailed quantification of benefits of
pollution controls in Europe. It has been used extensively for
European policy assessments including work on the National
Emission Ceilings Directive and the UN/ECE Gothenburg
Protocol under the Convention on Long Range
Transboundary Air Pollution, directives on air quality including
the Clean Air For Europe (CAFE) Directive, directives on fuel
quality and directives on emission limits for industry.
The model takes dispersion data from the EMEP or GAINS
models and provides a detailed quantification of effects on
health, including various morbidity impacts (on chronic
bronchitis, hospital admissions, etc.) and mortality, and
effects on building materials and crops. Extension of the
model for quantification of effects on ecosystem services is
currently under consideration.
Analysis then continues to monetization of quantified effects,
permitting final results to be used in cost-benefit analysis
using information on abatement costs from models such as
GAINS. The model can be applied at any desired geographic
scale and over any area of interest provided that appropriate
pollution and population data are available.
Further information on the methods, data, and assumptions
that underpin the GAINS and ALPHA models are available
on the website of the EC4MACS Project4.
3.1 Emissions Analysis and Inputs
The analysis first investigated the reduction in emissions of
greenhouse gases in the EU and the associated reductions
in emissions of sulphur dioxide (SO2), oxides of nitrogen (NO
and NO2, together referred to as NOx), and fine particles
(PM2.5), but excluding the greenhouse gas nitrous oxide (
N2O) and volatile organic compounds (VOCs).
The analysis was undertaken for two scenarios, a reference
(baseline) scenario out to 2050 and a mitigation scenario
designed to limit global temperature to 2°C compared to
pre-industrial levels. The emission scenarios are described in
the box below.
Air Quality
Emission Scenarios
The scenarios assessed in ClimateCost were originally
developed by Russ et al (2009) using the POLES
(Prospective Outlook for Long term Energy System) world
energy sector model and the GEM-E3 (General Equilibrium
Model: Energy, Economy, Environment) multi-sector general
equilibrium model. The scenarios were developed to assess
the technological and economic effects of a 50% likelihood
of limiting global temperature increase to 2°C. Within the
analysis, POLES provided analysis of the technologies of the
energy sector at a global scale, computing the direct cost of
reducing emissions in the energy sector, while the GEM-E3
model used a multi-sector perspective that allows
assessment of the economic consequences in the whole
economy, therefore assessing the direct and indirect effects
of mitigation policies.
In setting emission levels by country under the Mitigation
Scenario, the modelling accounted for both efficiency and
equity to prescribe alternative burden sharing options,
through consideration of: GDP per capita as an indicator of
wealth and ability to pay; the energy intensity of the
economy as an indicator of the potential to reduce
emissions; GHG emission trends as an indicator of those
that have taken early action (and constrain subsequent
ability to reduce emissions); and recent levels of population
growth.
These four criteria were brought together to provide a central
scenario, which has been adopted in this analysis. This
scenario includes an assumption of imperfect operation of
global carbon markets (as opposed to perfect trading or no
trading at all), in which international trading gradually
develops over time, bringing in more and more countries.
The modelling includes some account of the 2008/9
economic crisis through IMF forecasts made in 2008, though
this seems likely to have been too optimistic in terms of
economic recovery in the USA and Europe.
The GHG reductions in the Mitigation Scenario are primarily
from energy efficiency measures (accounting for roughly half
of the global reduction in 2020-2030). Significant reductions
in GHG emissions are also made through use of carbon
capture and storage and fuel switching. The latter covers a
move from (e.g.) coal and oil to lower carbon fossil fuels or to
renewables and nuclear. The sectors contributing most to
emission reductions are power generation followed by other
industries, with a modest contribution from the transport and
domestic sectors. Projected total emissions of CO2 for the
EU27 in the Baseline and Mitigation Scenarios are shown in
Figure 2.
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Figure 2. Projected total
emissions of CO2 for the EU27,
2005 to 2050.
3.2. Assessment of Impacts
The analysis of co-benefits has undertaken a multi-pollutant,
multi-effect analysis up to the year 2050. The pollutants
covered were SO2, NOx, VOC, NH3, PM2.5 and the effects
considered were human health, acidification and
eutrophication, as shown in Table 1 below.
The first step was to assess the effects of economic
development and emissions from the POLES scenario (see
box above) on air quality concentrations in Europe through
to 2050. This was undertaken in the GAINS model (Amann,
2008), which assesses the formation and dispersion of
pollutants in the atmosphere. The GAINS model was then
used to assess the key health impacts from fine particulate
matter and ground-level ozone, as well as a number of
ecosystem impacts from acidification and eutrophication.
This was complemented with the use of the ALPHA model
which covers a wider set of health and environmental
impacts, and also undertakes monetary valuation.
Health
The health impact assessment used here is based on
methods and quantification steps developed over a number
of years. There is a good level of consistency in the methods
between different groups undertaking this work for example
in Europe, the USA, and globally for the World Health
Organization (WHO). These methods have been subject to
extensive review (e.g. Krupnick et al, 2005) and found to be
fit for purpose and reflective of the current state of science5.
Mortality: Following the advice of an earlier expert group
convened by WHO-Europe under the CAFE Programme6,
the Health Impact Assessment was performed against
exposure to ozone and fine particles, considering the acute
effects on mortality – as reflected by premature mortality
(ozone) – and the longer-term changes in life expectancy
(sometimes termed chronic mortality) from particles. Note
that the particles considered include primary particulate
emissions (emitted directly) and secondary particulates that
form in the atmosphere following the release of SO2, NOx
and NH3. In line with WHO advice, the analysis treats all
particles, irrespective of source and chemical composition,
as equally harmful.
The outputs are reported as the cumulative years of life lost
(YOLL) from PM pollution and the additional cases of
premature mortality from ozone pollution. For acute mortality
from ozone, the analysis quantifies the number of ‘premature
deaths’ (deaths brought forward)7.
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5 The health impact assessment has been further substantiated by recent epidemiological research, e.g. by Smith et al (2009, a paper that also demonstrates
links between climate and air quality policies), Pope et al (2009a, b), and others.
6 The recommendations of WHO-CLRTAP Task Force on Health (TFH) (http://www.unece.org/env/documents) and the WHO “Systematic Review of Health
Aspects of Air Quality in Europe” (http://www.euro.who.int/document/e79097.pdf) were key to the development of quantification methods for assessing health
impacts of air pollution, the WHO-sponsored meta-analyses of the acute effects of PM and ozone based on studies in Europe
(http://www.euro.who.int/document/e82792.pdf). The process also drew on the answers to follow-up questions
(http://www.euro.who.int/document/e82790.pdf) of the CAFE Steering Group.
7 This wording signifies that many people whose deaths are brought forward by acute exposure to ozone in particular have serious pre-existing cardio-respiratory
disease and so in at least some of these cases, the actual loss of life is likely to be small – the death might have occurred within the same year and, for some,
may only be brought forward by a few days.
Table 1 Pollutants and Effects Considered.
Emissions Reduced and Coverage Against Effects
Air Pollutants and Effects SO2 NOx NH3 VOCs Primary PM2.5
Fine particles – health     
Ozone – health  
Acidification   
Eutrophication  
Other health impacts. The health impact assessment in
GAINS addresses mortality only. For other non-fatal health
effects (morbidity), the ALPHA model is used. This model
also assesses mortality and morbidity impacts in monetary
terms.
The method used here was based on the CAFE CBA
methodology (Holland et al, 2005a; b; Hurley et al, 2005)
and response functions developed as part of the EC CAFE
programme8.
For PM and ozone morbidity, impact functions were used to
assess the health effects of acute exposures (from
observation of response to day-to-day variations in ambient
PM) and long-term (chronic) exposures. A list of the health
impacts covered is provided in the Appendix.
Other environmental impacts. The study used the ALPHA
model to quantify and monetise impacts to building materials
and crops, focusing on the two major categories of impact in
Europe: crop losses from ozone exposure; and damage to
building materials from acidic deposition.
Air pollution has a significant influence on agricultural and
horticultural production. The analysis used the results of
previous studies (Holland and Watkiss, 2002: Holland et al,
2005c) that have considered the effects of ozone on crop
yield. The valuation of impacts on agricultural production is
reasonably straightforward, and estimated yield losses are
valued using world market prices, as published by the UN’s
Food and Agriculture Organization9. It is highlighted that
these do not consider changes in the productivity of
grassland and hence of livestock.
Air pollution is also associated with a number of impacts on
materials (see Box 1). The analysis again used the results of
previous studies (Holland and Watkiss, 2002: Holland et al,
2005c) that have quantified these impacts using dose-
response (damage function) relationships from the UNECE
ICP Task Force on Materials programme10. It is highlighted
that these only consider quantification of ‘utilitarian’ material
damage, and do not consider particle emission on building
soiling or buildings of historic or cultural value.
Ecosystems. The GAINS model was used to assess the
impacts of air pollutant deposition on ecosystems. The
analysis considered the area of forests and ecosystems that
exceed ‘critical loads’ for acidification and nutrient nitrogen
deposition. These critical loads represent a quantitative
exposure, below which no significant harmful effects on
(specific) sensitive elements occur. In the analysis here, the
area exceeding these critical threshold levels is assessed.
The study did not attempt the economic valuation of
ecosystem impacts. Such an analysis would require
knowledge of specific effects (change in species richness,
productivity, etc.) over extended time scales and appropriate
models are not available. Data for valuation of most impacts
to ecosystems are also unavailable, or so specific that
generalisation to the broader environment cannot be carried
out with confidence. Consideration was given to various
recent studies (NEEDS, 2006; Hettelingh et al, 2009; Jones
et al, 2011). These approaches, which address the change
in ecosystem services, provide a promising avenue for future
quantification, but they are difficult to apply at the scale
considered here.
More details of the impact methods (for health,
environmental impacts and ecosystems) are described in the
reports from CAFE and the EC4MACS study (Holland et al,
2005a, 2008; Amann et al, 2008). It is highlighted that these
methods continue to evolve, and there are some recent
developments which could be used in future assessments11.
3.3. Monetary Valuation and
reporting of economic values
The impacts on human health are more difficult to value,
because there are no observed market prices. However, it is
possible to derive monetary values for this non-market
sector, by considering the total effect on society’s welfare.
This requires analysis of three components which each
capture different parts of the total effect. These are:
Air Quality
8 The methodology developed was the subject of intense consultation in 2003 and 2004 with stakeholders from the European Union Member States, academic
institutes, environment agencies, industry and non-governmental organisations. It was also subject to formal peer review by senior experts in the USA and
Europe.
9 World market prices are used as a proxy for shadow price on the grounds that they are less influenced by subsidies than local European prices.
10 ICP Materials. Dose-response functions. http://www.corr-institute.se/ICP-Materials/html/dose_response.html
11 As highlighted by Hurley, Miller and Shafrir (2011) the future health impact assessment could include a cause-specific approach (Pope et al, 2009; Krewski et al,
2009; Amann and Schopp, 2011), use country specific life tables, consider long term exposure to ozone on mortality (Jerrett et al, 2009) and use European chronic
bronchitis studies (Schindler et al, 2009).
• The resource costs i.e. medical treatment costs;
• The opportunity costs, in terms of lost productivity; and
• Dis-utility i.e. pain or suffering, concern and
inconvenience to family and others.
The first two components can be captured relatively easily.
Techniques are also available to capture the third
component, by assessing the ‘willingness to pay’ or the
‘willingness to accept compensation’ for a particular health
outcome. These are derived using survey-based “stated”
preference methods and/or “revealed” preferences methods
that are based on observed expenditures such as on
consumer safety.
ClimateCost has made use of existing unit estimates for
health based impacts, and adopts established benefit value
transfer procedures to apply these values.
However, there is substantial debate concerning the correct
approach to valuation of mortality risks in the context of air
pollution. These can be valued using a long-established
metric, the value of statistical life (VSL – also known as the
value of a prevented fatality, VPF), but changes in life
expectancy can also be valued using the value of a life year
(VOLY), which provides a way of accounting for differing
lengths of remaining life expectancy. Both approaches are
used in the literature and both have strengths and
weaknesses. ClimateCost has therefore used both for
valuation. This is also the approach used in the European
Commission’s Clean Air For Europe (CAFE) Programme,
following peer review guidance.
The main results reported below use a VOLY of €60,000,
which is consistent with the (low) value used in EC CAFE
assessment. The VSL is also applied, using values of €1.1
million and €3.8 million. The lower figure is also broadly
consistent with the EC CAFE analysis. In the sections below,
numbers are first presented for the VOLY, using the mid
value of €60,000. Results are then provided in a later
section based on the VSL.
For morbidity (non-fatal) impacts, a literature review has
assessed the most appropriate values. Note that for acute
mortality from ozone, the analysis quantifies the number of
‘premature deaths’ (deaths brought forward) and these
cases are valued using a VOLY approach, assuming that on
average, each premature death leads to the loss of 12
months of life.
The same monetary values for mortality risk and morbidity
are used across all European countries.
Consistent with all sector-based analysis in ClimateCost, the
economic valuation results below are presented in terms of
constant 2005 prices in Euros over future years, without any
adjustments or discounting. The results are presented in this
way to facilitate direct comparison, over time, and between
sectors. However, subsequent policy analysis that looks at
the costs and benefits of mitigation policy would need to
work with present values (i.e. values that are adjusted and
discounted as with standard economic appraisal). This
analysis is included in other parts of the ClimateCost study
3.4 What is included and
excluded in the analysis?
When considering the results in this technical briefing note, it
is important to be explicit about what is included or
excluded, and on the areas of uncertainty covered.
The results below only present the effects of mitigation policy
on air quality – they do not include analysis of how climate
change might affect air quality concentrations more generally.
Climate change has the potential to increase future ambient
background ozone concentrations in summer months, and
also influence the frequency and intensity of high
concentration (ozone episodes). However, the evidence for
these effects is by no means well understood, and the current
evidence indicates there could be potential positive as well as
negative effects of climate change on ozone formation.
Similarly, climate change could affect the formation, transport
or (wet) deposition rates of particulate species, though both
positive and negative effects are possible.
The impacts for building materials are monetised using repair
and replacement costs. While a similar approach could, in
theory, be applied to historic and cultural buildings, there is a
lack of data on the stock at risk (number of such buildings
and an inventory of the materials in them), and also the
relevant valuation of building damage, thus the numbers
reported here only include utilitarian buildings.
Finally, despite the large, well-documented literature available
on these effects, it is not currently possible to conduct an
economic analysis of the effects on ecosystems. The
omission of these effects therefore significantly
underestimates the total reported benefits, and it is
recommended that the physical benefits to ecosystems are
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considered directly alongside the economic values
presented in the findings.
4. Results – impacts and
economic costs of air
pollution
4.1 European Emissions
The emission trends for the EU under the Baseline and
Mitigation Scenarios are summarised Table 2 (and plotted in
Figure 3) based on data generated by GAINS. The analysis
includes current policies and so there are large emission
reductions in the baseline scenario up to 2030, which
thereafter remains broadly constant. Note that the baseline
includes all emission limit values and fuel quality standards,
as used in the analysis for the revision of the National
Emission Ceilings (NEC) Directive (Amann et al., 2008).
The results in Table 2/Figure 3 show:
• The pollutants that show the greatest reductions under
the mitigation scenario are SO2 and NOx. This is not
surprising as these pollutants are closely linked with CO2
emissions, as they are products of fossil fuel combustion.
Air Quality
Table 2. Emissions (million tonnes/year) 2005 to 2050 in Europe (EU27), under the baseline and mitigation scenarios, and the benefits of
mitigation (Mtonnes and % reduction in year of emission).
Million tonnes per year in EU27, Baseline scenario
2005 2020 2030 2050
SO2 8053 2411 2083 2239
NOx 11221 5219 3991 4034
PM2.5 1595 931 831 877
Million tonnes per year in EU27, Mitigation (2°C) scenario
2005 2020 2030 2050
SO2 8053 2086 1440 906
NOx 11221 4854 3200 2190
PM2.5 1595 932 813 710
Net benefits of Mitigation – million tonnes and % reduction from the baseline
2005 2020 2030 2050
SO2 0 325 (14%) 643 (31%) 1333 (60%)
NOx 0 365 (7%) 791 (20%) 1844 (46%)
PM2.5 0 -1 (0%) 18 (2%) 167 (19%)
Source GAINS, Rafaj et al (2011).
• There is little difference between the Baseline and
Mitigation Scenario emissions through to 2020. This is
due to the existing legislation that targets air quality,
such as the Euro standards for motor vehicles, the
Large Combustion Plant Directive, and measures to
improve fuel quality such as the Directive on the sulphur
content of certain liquid fuels.
• A significant difference for emissions of PM2.5 is only
apparent for 2050.
• There is very little change in the Baseline Scenario after
2030, as legislation currently in place will have taken its
full effect by then.
For the other major air pollutants, VOC and NH3 (not shown
in the Table and Figure above) the emission reductions are
much lower because these pollutants are less affected by
decarbonisation of the energy system. For VOCs, emission
benefits are estimated to be 2% in 2030 rising to 9% in
2050. For ammonia, emissions are similar in the baseline
and mitigation scenario.
The mitigation scenario is
most effective in reducing
oxides of sulphur and
nitrogen, with reductions of
60% and 46% respectively in
2050 in Europe, while
reductions in particulate
matter are lower at 19%.
4.3 Health
The reduction in air quality concentrations in Europe has
large potential health benefits. The analysis has quantified
and monetised these benefits, comparing the projected
impacts from air pollution under the baseline and mitigation
scenario.
The first step in this analysis is to estimate the change in air
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Key to the figures:
The graphs show the emissions of three main air pollutants SO2 (top)
NOx (middle) and PM2.5 (bottom) in 2005, 2020, 2030 and 2050, for a
baseline scenario (BAS) and the mitigation scenario (MIT), with each
bar also showing the breakdown of emissions by sector.
Figure 3. European (EU27) emissions of SO2, NOx, and PM2.5,
annual Million tonnes, from 2005 to 2050 under the Baseline and
Mitigation Scenarios. (Source GAINS, Rafaj et al (2011)).
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quality concentrations, and link this with population to
estimate the population-weighted-exposures.
Figure 4 below shows the ambient concentrations of
PM2.5 up to 2050 in the EU, showing the baseline (BAS)
and mitigation scenario (MIT) over time. This is
compared against the WHO target guideline levels on
PM, shown in red (WHO, 2005). At the current time there
is still widespread non-compliance, but by 2050 most
countries will be below the target levels. Nonetheless,
under the mitigation scenario, all EU countries fall within
the WHO target level. Mitigation target therefore has the
benefit of ensuring European wide compliance.
Furthermore, there are still residual health impacts that
are thought to occur below the target level. Under the
mitigation scenario, average ambient concentrations of
PM2.5 in the EU are by 36% lower than the Baseline
projections by 2050.
Figure 4 Ambient concentrations of PM2.5 (population weighted,
annual mean) for the Baseline and the Mitigation scenarios in
the EU27. Ranges indicate variations over EU countries.
Key:
The figure shows the mean EU27 population weighted PM
concentrations under the ___ baseline and – - – mitigation
scenarios. These can be compared to the WHO target guideline
levels for PM, shown as -x-. The grey and green shaded areas
show the upper range for individual countries. Note that under
the mitigation scenario, all EU countries in 2050 are within the
WHO target level, while under the baseline, some still remain
above. 
Source GAINS, Rafaj et al (2011).
Table 3 presents the statistical loss of life expectancy
estimated in the GAINS model from air pollution. This
shows that across Europe, the population currently loses
an average of 7 months of life expectancy (on average)
from air pollution. By 2020, this fall to around 4 months
of life lost on average, for both the baseline and
mitigation scenario. 
However, under the mitigation scenario, the loss of life
expectancy continues to fall from 2030 to 2050, down to
2 months on average, and thus mitigation achieves a
benefit of a month of life expectancy compared to the
baseline in 2050 (a 35% reduction in the loss of life
expectancy compared to the Baseline).
A full breakdown by Member State is provided in the
Appendix. It is stressed that is an average across the
whole population, and the population as a whole will vary
in their sensitivity to air pollution. 
Air pollution currently has a
significant impact in
reducing life expectancy in
Europe, by 7 months on
average.  While current air
pollution legislation is
expected to halve this by
2050, mitigation policy
would increase life
expectancy by 1 month on
average.
Figure 5 shows the variation in these impacts across
Europe, for 2030 and 2050 under the baseline and
mitigation scenario. The largest losses of average life
expectancy are in Belgium and the Netherlands. The
smallest are in the fringes of Europe, for example in
Finland, Ireland and Sweden. These differences are due
to trans-boundary pollution. 
Air Quality
0 
5 
10 
15 
20 
2005 2020 2030 2050 
!g
 P
M
2.
5/
m
3 
EU-27 BAS All regs 
MIT All regs 
BAS Mean 
MIT Mean 
WHO Target 
 
 
 
 
 
 
 
 3
m/5.
PM
2
 
 
 
 
 
 
 
 
PM
2
g!
 
 
 
 
 
 
Policy Brief
06
16/17
2030
Baseline
2030
Mitigation
2050
Baseline
2050
Mitigation
Figure 5. Statistical loss of life expectancy due to anthropogenic PM2.5, (months), left baseline, right mitigation scenario (Source GAINS, 
Rafaj et al, 2011).
Table 3. Statistical loss of life expectancy in months (Source GAINS, Rafaj et al (2011)) under the baseline and mitigation scenarios, and the
benefits of mitigation.
Loss of life expectancy from air pollution – months, Baseline scenario
2005 2020 2030 2050
Baseline 7.3 3.7 3.1 3.1
Loss of life expectancy from air pollution – months, Mitigation (2°C) scenario
2005 2020 2030 2050
Mitigation (2C) 7.3 3.5 2.6 2.0
Net benefits of Mitigation
2005 2020 2030 2050
Benefits of mitigation scenario 0.2 0.5 1.1
Notes values are for adults older than 30 years and attributable to exposure to PM2.5 from anthropogenic sources
As Figure 5 shows, under the mitigation scenario (bottom
right), the life expectancy losses are reduced over all of
Europe.  Under the baseline (bottom left), Belgium, the
Netherlands and central and eastern Europe still have
particularly high life expectancy losses in some areas.
The study has also estimated the health impact of ozone
related mortality. Note that this only considers the reduction
in ozone precursor emissions with mitigation: it does not
consider the effects of climate change directly on ozone
formation. Under the Mitigation scenario, there is a reduction
in the number of premature fatalities from ozone, by 6% in
2030 and 15% in 2050 relative to the Baseline. In absolute
terms, the mitigation scenario leads to 2800 fewer
premature deaths from ozone in Europe by 2050 compared
to the Baseline.
Air Quality
Table 4. Health impacts (cases per year) for the EU27 in the Baseline and Mitigation Scenario in 2050, and Co-Benefits of Mitigation.
Cases per year
Results for 2050 Baseline Mitigation Co-benefit
Acute mortality (all ages) deaths O3 24,259 20,884 3,374
Respiratory hospital admissions (65yr +) O3 27,869 24,075 3,794
Minor restricted activity days (15-64yr) O3 36,150,820 31,214,804 4,936,016
Respiratory medication use (adults 20yr +) O3 16,688,648 14,411,345 2,277,303
Chronic mortality, life years lost PM 1,387,251 904,805 482,446
Infant Mortality (1 month - 1yr) deaths PM 201 129 72
Chronic bronchitis (27yr +) new incidence PM 76,839 50,282 26,556
Respiratory hospital admissions (all ages) PM 28,933 18,968 9,965
Cardiac hospital admissions (all ages) PM 17,844 11,698 6,146
Restricted activity days (RADs 15-64yr) PM 124,127,047 81,419,761 42,707,287
Respiratory medication use (children 5-14yr) days PM 1,391,384 917,130 474,254
Respiratory medication use (adults 20yr +) days PM 13,643,560 8,933,242 4,710,318
Lower respiratory symptom days (children 5-14yr) PM 71,501,674 47,130,298 24,371,376
Lower respiratory symptom days (15yr +) PM 137,690,472 90,189,476 47,500,996
aseli e Co-benefit
The ALPHA model provides a more extensive quantification
of health impacts, including a number of effects on
morbidity, as well as valuing all health outcomes in monetary
terms.
The results for the Baseline and Mitigation Scenarios for
2050 are presented in Table 4, in terms of the physical health
effects (outcomes or cases per year). The table also shows
the difference between the two scenarios (i.e. the ‘co-
benefit’). Values for 2020, 2030 and 2050 are presented in
the Appendix
By 2050 the results for the EU27 in Table 4 reveal that:
• For fine particles, the annual co-benefits are estimated at
480,000 fewer life years lost to air pollution12, 72 fewer
cases of infant mortality, 27,000 fewer new cases of
chronic bronchitis, 16,000 fewer hospital admissions and
in total around 120 million fewer person days of
restricted activity, respiratory medication use and lower
respiratory symptoms.
• For ozone, the Mitigation Scenario leads to 3,400 fewer
deaths brought forward each year, 3,800 fewer hospital
admissions and a reduction of around 7 million person
days of ‘minor restricted activity’ and respiratory
medication use.
The mitigation scenario leads
to an estimated annual benefit
of 480,000 life years gained, as
well as 27,000 avoided cases
of chronic bronchitis, 20,000
fewer annual hospital
admissions and around 
127 million avoided minor
symptom days each year by
2050 in the EU27.
These benefits are then converted to monetary equivalents.
The values for 2050 presented below in Table 5. Full results
are presented in the Appendix. The value of a life year lost
metric has been used in these table, using a VOLY of
€60,000. The impact on the estimates with the use of the
value of statistical life is presented in a later section. The
greatest impacts – and co-benefits – arise from the chronic
effects on mortality and chronic bronchitis and the acute
effects on restricted activity days, which are all associated
with exposure to fine particles. 
Figure 6 shows how the total co-benefits increase over time.
The EU27 benefits total €9 billion, €20 billion and €43
billion/year respectively in 2020, 2030 and 2050 (current
prices, no discounting). The benefit of €43 billion in 2050
equates to over €78 for each EU citizen.
The co-benefits over time are shown in Figure 7 at the
country level. 
For an explanation of the country abbreviations, see
Appendix 1.
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12 Note that under the GAINS analysis, the change in life expectancy is calculated for the population as a whole over the lifetime of the individuals (assuming
similar pollution exposure). In the ALPHA analysis this metric is estimated in an annualised form to give an annual number of life years lost which can then be
monetised. 
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Figure 6. Annual Health Co-benefit (Net benefit of the Mitigation
Scenario relative to the Baseline) (source ALPHA). All figures in
€Billions/year (current prices, undiscounted, VOLY estimate). 
Air Quality
Table 5. Monetised health effects for the EU27 for the Baseline and Mitigation Scenario for 2050, and Co-Benefits of Mitigation. All figures in
€millions/year (current prices, undiscounted). VOLY estimates for mortality. Source ALPHA.
€millions/year 
Results for 2050 Baseline Mitigation Co-benefit 
Acute mortality (all ages) deaths O3 1,456 1,253 202
Respiratory hospital admissions (65yr +) O3 64 55 9
Minor restricted activity days (15-64yr) O3 1,591 1,373 217
Respiratory medication use (adults 20yr +) O3 17 14 2
Chronic mortality, life years lost PM 83,235 54,288 28,947
Infant Mortality (1 month - 1yr) deaths PM 1,147 737 410
Chronic bronchitis (27yr +) new incidence PM 16,597 10,861 5,736
Respiratory hospital admissions (all ages) PM 67 44 23
Cardiac hospital admissions (all ages) PM 41 27 14
Restricted activity days (RADs 15-64yr) PM 11,916 7,816 4,100
Respiratory medication use (children 5-14yr) days PM 1 1 0
Respiratory medication use (adults 20yr +) days PM 14 9 5
Lower respiratory symptom days (children 5-14yr) PM 3,146 2,074 1,072
Lower respiratory symptom days (15yr +) PM 6,058 3,968 2,090
Total 125,350 82,521 42,828
Baseline Co-benefititigation
The economic health
cobenefits of the mitigation
scenario in Europe (EU27) are
estimated at €9 billion/year 
by 2020, rising to €20
billion/year by 2030 and 
€43 billion/year by 2050 
(VOLY approach).
As highlighted earlier, two approaches can be used for
valuing the change in risk of mortality – the VOLY and the
VSL. In ClimateCost both have been used. To further reflect
uncertainty, the following ranges have been used:
• VOLY: €37,500 to €215,000 with the best estimate of
€60,000
• VSL: €1.1 million, €3.8 million and €5.6 million. 
The values in the Tables and Figures above use the VOLY
mid estimate (€60,000). Table 6 presents the effects on the
total results (all health impact) with the different values for
mortality valuation above. It is highlighted that the use of a
low VSL estimate (of just over €1 million) increases the co-
benefits to €94 billion in 2050, while using values from the
recent literature increases this significantly. 
It is also possible to assess these co-benefits against the
GHG emission reductions, to estimate the co-benefit per
tonne of GHG reduced. This provides a useful way for
communicating the size of the benefits. 
The emissions of CO2 for the EU27 were shown in Figure 2.
Current 2005 emissions were just under 4 billion
tonnes/year, and fall to under 1 billion tonnes/year by 2050
under the mitigation scenario (around an 80% reduction on
the 2005 baseline). 
Using the values presented in Figure 6, the air quality co-
benefits are estimated at €24 a tonne of CO2 mitigated in
2020, €21/tCO2 in 2030, and €24/tCO2 by 2050. As
elsewhere, these figures are estimated using the mid-
estimate of the VOLY (€60,000). The values would be higher
with the use of VSL estimates.”
When expressed against the
CO2 reductions achieved, the
air quality co-benefits of the
mitigation scenario are around
€24 a tonne of CO2 across the
period.
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Figure 7. Annual Health Co-benefit by Country (Net benefit of the Mitigation Scenario relative to the Baseline) (source ALPHA). All figures in
€Millions/year (current prices, undiscounted, VOLY estimate). 
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4.3 Crops and Materials
Analysis of the effects of changes in emissions on materials
has focused on SO2 and its impact on materials used in
‘utilitarian’ buildings. The material results are shown in Table
7 below, and can be seen to be a small fraction (0.4%) of the
health co-benefits in Table 6. Note that the analysis of
materials damage omits damage to cultural heritage and
damage from pollutants other than SO2 (e.g. effects of other
acidifying gases). 
The results of the effects of ozone on crops are presented in
Table 8 below. Given the non-linearities in ozone chemistry,
the approach used only gives a very approximate result of
the change over time. However, total co-benefits of reduced
crop damage are again a small fraction of the health impacts
quantified in Table 6 above.
Air Quality
Table 6. Mitigation Co-benefits in the EU27 based on different mortality valuation approaches and unit values. All figures in €millions/year
(current prices, undiscounted).
Valuation metric and Net benefits of Mitigation – 
unit cost €millions/year (current prices, undiscounted).  
2020 2030 2050
VOLY low (€37,500) 6,893 14,556 31,606
VOLY mid (€60,000) 9,450 19,865 42,828
VOLY high (€215,000) 26,560 55,504 118,325
VSL low (€1.1 million) 15,680 36,142 94,025
VSL mid (€3.8 million) 47,425 110,305 292,009
VSL high (€5.6 million) 68,652 159,901 424,471
Table 7. Damage to building materials from SO2 emissions for the EU27 under the Baseline and Mitigation Scenario (€Million/year, current
prices, undiscounted).
€Million/year   
2020 2030 2050 
Total: Baseline Scenario 509 434 447 
Total: Mitigation Scenario 442 303 183 
Co-benefit 
(difference between the 67 131 264
two scenarios)
4.4 Ecosystems (Critical Loads
Exceedance)
The protection of ecosystems has been the main stimulus
for tackling transboundary air pollution in Europe, particularly
concerns about ‘acid rain’ in the 1970s and 1980s, which
was responsible for acidification of freshwater ecosystems
and forest decline. 
Since then, there have been significant reductions in the acid
burden to ecosystems, particularly in emissions of SO2.
There have also been large reductions in emissions of NOx,
but the fall in NH3 emissions has been more modest.
One result of such action is that the area of ecosystems
subject to exceedance of the critical load for acidification
has declined substantially since the 1970s. Table 9 shows
the area of forest in excess of the critical loads for
acidification. In 2005, 20% of the forest area of the EU27
was subject to critical load exceedance for acidification. By
2020 this is projected to fall to 7% under the Baseline
Scenario, because of existing legislation. However, under the
Mitigation Scenario the area subject to exceedance more
than halves between 2020 and 2050, to less than 3%, and
the mitigation scenario reduces the forest area exposed to
acidification deposition by 42 thousand km2. 
Figure 8 shows the distribution of the Baseline and Mitigation
scenario exceedences over Europe. These are concentrated
in a band running across Northern Europe from the west of
France to Ukraine. 
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Table 8. Damage to crops from emissions of ozone precursors for the EU27 (€M/year, current prices, undiscounted)
€Million/year 
Effects of NOx 2020 2030 2050 
Total: Baseline Scenario 1,621 1,208 1,209 
Total: Mitigation Scenario 1,510 969 642 
Co-benefit (difference
between the two scenarios) 111 239 567
Effects of VOCs 2020 2030 2050
Total: Baseline Scenario 886 857 884
Total: Mitigation Scenario 884 842 813
Co-benefit (difference
between the two scenarios) 2 15 71
Total co-benefit 113 254 638
Air Quality
Table 9. Area of forest (and % of total forest) in excess of the critical loads for acidification in the EU27 (2005-2050), for the Baseline and the
Mitigation scenarios.
Baseline scenario
2005 2020 2030 2050
Forest area with acid deposition 253 89 73 78
exceeding critical load (thousand km2) (20%) (7%) (6%) (6%)
and % of total area
Mitigation (2°C) scenario 
2005 2020 2030 2050
Forest area with acid deposition 253 77 53 36
exceeding critical load (thousand km2) (20%) (6%) (4%) (3%)
and % of total area
Net benefits of Mitigation
2005 2020 2030 2050
Forest area with acid deposition 11 21 42
exceeding critical load (thousand km2) (1%) (2%) (3%)
and % of total area
Table 10 reports the extent of exceedance of the critical load
for eutrophication. In the Baseline this falls from 72% in
2005 to 56% by 2050. Under the Mitigation Scenario, the
extent of exceedance falls to 48% by 2050 – an
improvement, but there is still a high level of residual
exceedance.
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Figure 8. Percentage of forest area (%) affected by exceedance of the critical load for acidification
2030
Baseline
2030
Mitigation
2050
Baseline
2050
Mitigation
Source GAINS, Rafaj et al (2011).
In percentage terms, the difference between the two
scenarios is lower than for acidification. This is to be
expected as ammonia emissions – which contribute to
eutrophication – are not affected much under the mitigation
case. Nonetheless, the total area that falls below the critical
load for eutrophication is significant under the mitigation
scenario, estimated at 145 thousand km2 by 2050. The
pattern of exceedances across Europe is shown in Figure 9.
The extent of the eutrophication problem at a national level is
shown in Figure 10. In 2005, slightly more than half of the
EU’s Member States were estimated to have eutrophication
exceedance across more than 95% of their ecosystem area.
By 2050 this falls to seven Member States under the
Baseline Scenario and five under the Mitigation Scenario.
However, it is notable that in 2050 there are still more than
half of the EU27 countries which have exceedances over
more than 50% of their ecosystem area.
Air Quality
Table 10. Area of ecosystems (and % of total) in excess of the critical loads for eutrophication in EU27 (2005-2050), for the Baseline and the
Mitigation scenarios.
Baseline scenario
2005 2020 2030 2050
Ecosystem area with nutrient nitrogen 1176 949 908 926
deposition exceeding critical load (73%) (59%) (56%) (57%)
(thousand km2) and % of total area
Mitigation (2°C) scenario 
2005 2020 2030 2050
Ecosystem area with nutrient nitrogen 1176 926 850 783
deposition exceeding critical load (73%) (57%) (53%) (48%)
(thousand km2) and % of total area
(48%)Net benefits of Mitigation
2005 2020 2030 2050
Ecosystem area with nutrient nitrogen 23 58 144
deposition exceeding critical load (1%) (4%) (9%)
(thousand km2) and % of total area
Source GAINS, Rafaj et al (2011).
The mitigation scenario
reduces the forest area
exposed to acidification
deposition exceeding critical
loads by 42 thousand km2 in
2050 and the sensitive
ecosystem area exposed to
eutrophication by 144
thousand km2. 
4.5 Avoided Abatement Costs
Mitigation policies also have an additional ancillary benefits
through avoiding the need to implement air pollution
measures required by legislation. The mitigation scenario will
reduce the costs of air pollution abatement because of the
lower levels of fossil fuels, which in turn requires fewer
installations of air-pollution control equipment.
In Europe, the legislation in the Euro standards and the
Industrial Emissions Directive (IED) lead to additional costs
on polluters (consistent with the polluter pays principle) and
requires equipment to reduce pollution. For example, under
the IED, coal fired power stations need to be fitted with
technologies such as bag filters or electrostatic precipitators
to reduce emissions of particles, flue gas desulphurisation to
reduce SO2 releases and NOx controls such as selective
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Figure 9. Percentage of ecosystem area affected by exceedance of the critical load for nutrient nitrogen (Source GAINS, Rafaj et al, 2011).
2030
Baseline
2030
Mitigation
2050
Baseline
2050
Mitigation
Source GAINS, Rafaj et al (2011).
catalytic/non-catalytic reduction (SCR/SNCR). These
technologies incur capital expenditure and operating costs
for manpower, reagents, waste material disposal, etc. 
The GAINS model has calculated the difference in
abatement costs (for each pollutant) between the Baseline
and Mitigation Scenarios. These are estimated as the annual
savings (in 2005 prices) in future years13. 
The costs of implementing current legislation within the EU –
through to 2050 – are estimated at about 76 billion €2005 per
year (undiscounted) in the baseline scenario. The GAINS
calculation suggests that this cost can be halved by 2050
under a mitigation scenario, with the savings (co-benefits)
estimated at €36 billion/year by 2050 for the EU27. The
results are shown in Table 11.
The breakdown by sector is shown in Figure 11. The largest
part of these savings is related to the transport sector. In
respect of emissions, the largest reduction in abatement
costs is for NOx control, at about three quarters of the total,
with most of the remainder associated with savings for SO2
controls. Savings for control of PM14, VOCs and NH3 are
much more modest, reflecting the nature of the mechanisms
for reducing GHGs in the Mitigation Scenario.
The benefits by country are shown in Figure 12 below. The
country codes are listed in Appendix 1.
At the global level, the annual savings are much greater, and
are estimated by the GAINS model to be more than 250
billion Euros/year by 2050 (€2005, undiscounted). A
significant proportion of these – around one fifth – are in the
USA. Most of these benefits (in relative terms) arise in the
power sector, where control costs are reduced very
significantly, followed by the transport sector, which has the
highest absolute reductions.
While care needs to be taken in applying these cost savings
in any policy impact assessment to avoid double counting,
Air Quality
13 These are estimated as annualised costs (investment and fixed operating costs) in current prices for future years, using a 4% discount rate which is consistent
with the GAINS analysis. These are not discounted back to the current year i.e. to 2010.
2005 
Figure 10. Proportion of countries with varying levels of exceedance of the critical load for eutrophication by ecosystem area.
Baseline 2050 Mitigation 2050 
Data source: GAINS, Rafaj et al (2011).
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14 Note that many of the technologies that abate NOx also abate PM10, but in the analysis, the costs are counted against NOx reductions
Figure 11. Abatement costs total (billion) for sectors, 2005 to 2050, from climate policies (2005 prices, undiscounted).
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Table 11. Potential abatement costs, 2005 to 2050, under the baseline and mitigation scenarios. Source GAINS, Rafaj et al (2011). All
figures in €billions/year (2005 prices, undiscounted). 
Cost of abatement – billions of Euros per year in EU27, Baseline scenario 
2005 2020 2030 2050
Costs of abatement EU27 – baseline 46.8 85.1 92.2 82.0
Costs of abatement – billions of Euros per year in EU27, Mitigation (2°C) scenario
2005 2020 2030 2050
Costs of abatement EU27 – mitigation 46.8 80.2 75.8 46.3
Net benefits of Mitigation
2005 2020 2030 2050
Benefits of mitigation scenario 0 4.9 16.4 35.7
Source GAINS, Rafaj et al, 2011). 
they demonstrate that climate policy can reduce the
regulatory burden on business in some ways.
Mitigation also reduces the air
pollution abatement required
by legislation, leading to cost
savings for business. In the
EU27, these savings are
estimated at €36 billion/year
by 2050. 
4.6 Other Effects
The main measures for reducing emissions under the
Mitigation Scenario are improvements to energy efficiency,
fuel switching and the use of carbon capture and
sequestration (CCS). These have a broad range of effects
beyond the effects on greenhouse gas emissions and the air
pollutants considered in this TPBN (and the economic
consequences assessed by Russ et al in their 2009 paper
on the scenarios). Most of these are beneficial for society,
though there is some potential for negative impacts. The
following illustrates the additional benefits. These have not
been assessed in the ClimateCost project, but should be
considered in the wider discussion of mitigation co-benefits. 
Energy security: Climate policies that reduce the use of
fossil fuels through fuel switching or energy efficiency provide
important energy security benefits. These policies reduce the
demand for imports of fossil fuels and provide important
Air Quality
Figure 12. Abatement savings in 2030 to 2050, from climate policies. Source GAINS, Rafaj et al (2011). All figures in €millions/year (2005
prices, undiscounted). 
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For an explanation of the abbreviations, see Appendix 1.
macro-economic benefits associated with reduced energy
imports. This is important as 55% of Europe’s primary
energy is imported (CEC, 2011) and this figure will increase
slightly in future years under the baseline scenario. Second,
by reducing reliance on fossil fuels, these policies potentially
provide greater price stability (lower volatility). This is
particularly important given oil price fluctuations and price
spikes in recent years, and because fossil reserves are
primarily in regions with higher geopolitical risks. 
Risk of major accidents and legacy issues: A switch from
fossil fuels will reduce the risk of some types of major
accident. These include coal mining accidents, of which
there have been a number of events in recent years,
particularly in China, but also in the USA, New Zealand and
the UK (amongst others). They also include accidents
associated with oil and gas extraction and transport. These
are very varied in type, including oil spills from tankers,
accidents from rigs such as Piper Alpha in the North Sea
and Deepwater Horizon in the Gulf of Mexico. However,
some low carbon technologies are also not without risk of
accident, most notably the use of nuclear power during
operation, as at Fukushima, and from the storage of waste
over extended periods. Advocates of all these technologies
tend to argue that major accidents affecting their favoured
technology are not typical of the advanced technologies that
would be installed today, but nonetheless, accidents still
happen, despite the existence of sophisticated management
and inspection protocols intended to avoid them. These
risks are therefore important in balancing the overall ancillary
effects of alternative future pathways. Alongside the issues
of major accidents are legacy issues associated with nuclear
waste, and CO2 storage. 
Landscape and amenity: Widespread deployment of some
renewable technologies, notably wind turbines, could have a
significant impact on landscapes. Widespread deployment
of wind turbines will have an immediate and possibly large
effect on the amenity value of landscapes in the short to
medium term. 
The examples provided above only represent a short-list of
co-benefits/trade-offs of climate policies. There are other
potential areas that could also be added, notably possible
employment or growth opportunities (CEC, 2011). However,
they underline the fact that the consequences of climate
controls are far reaching and monetisation of these
additional issues is a priority for future analysis.
5. Co-Benefits in China and
India
While mitigation policy has potentially large co-benefits in
Europe, there are potentially even greater benefits for other
major emitters with higher current baseline pollution levels,
notably in China and India. These countries are increasingly
suffering air pollution problems similar to historic European
levels, and there is a growing awareness of the associated
health and environmental impacts. 
The ClimateCost study has therefore assessed the potential
co-benefits of mitigation in these countries. This has used
the GAINS model analysis, using a similar approach to that
outlined for Europe above.
Figure 13 below illustrates the baseline population weighted
concentrations of PM2.5 up to 2050 in China and India,
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Air Quality
Figure 13. Ambient concentrations of PM2.5 (population weighted, annual mean) for the Baseline and the Mitigation scenarios. Ranges
indicate variations over provinces/states.
Figure 14. Statistical loss of life expectancy (months) in China due to anthropogenic PM2.5 for the Baseline (left panel) and Mitigation (right
panel) scenarios in 2050.
Source GAINS, Rafaj et al (2011).
Figure 15. Statistical loss of life expectancy (months) in India due to anthropogenic PM2.5 for the Baseline (left panel) and Mitigation (right
panel) scenarios in 2050.
Source GAINS, Rafaj et al (2011).
showing the comparison of baseline (BAS) and mitigation
scenario (MIT) over time set against the WHO target
guideline levels on PM (WHO, 2005). Note these values can
be directly compared against the same plot for Europe in
Figure 4.
Unlike Europe, most of the regions of China and India have
concentrations that far above the WHO guideline level of 10
µg PM2.5/m
3. Under the mitigation scenario, average ambient
concentrations of PM2.5 in China and India are 47% and
63% lower, respectively, when compared to the Baseline
projections in 2050. In turn, these air quality improvements
lead to very large health benefits. 
In China, large health benefits start to arise in 2030, in line
with the changes in emissions of air pollutants between the
mitigation and baseline scenarios. By 2050, the loss in
statistical life expectancy due to PM2.5 is halved under the
Mitigation scenario, as shown in Figure 14, and compared to
the Baseline scenario, it increases life expectancy by nearly
20 months. The premature deaths attributable to ozone are
also reduced annually by 20,000 cases with mitigation. 
Similarly, in India, the mitigation scenario brings major
improvements after 2030. The gain in the statistical life
expectancy from mitigation policies is estimated at 30
months by 2050 (see Figure 15), while the projected
premature death-rates due to ground-level ozone are
reduced by 55,000 cases per year by 2050, relative to the
Baseline case.
The pollution reductions in the mitigation scenario would also
have very dramatic benefits in reducing acidification and
eutrophication loads in these countries, which are an
increasingly recognised problem. 
7. Discussion
The total co-benefits (health, materials and crops) of
reducing emissions under a mitigation scenario (consistent
with the EU 2 degrees target) are estimated to reach €44 to
€95 billion/year by 2050 (current prices, undiscounted). 
These benefits are significant when compared to the
underlying costs of mitigation, and accrue to the Member
States that are undertaking emissions reductions, with
benefits arising in the short-term. 
When expressed against the CO2 reductions achieved, the
air quality co-benefits of the mitigation scenario are around
€24 per tonne of CO2 across the period (mid estimate VOLY,
current prices).
It is highlighted that there remains some uncertainty over the
valuation of mortality. There is almost a factor of 10 variation
in the total health co-benefits between the most and least
conservative positions on mortality valuation (Table 6) though
there is much less difference (less than a factor of 2)
between the central values in use in policy (€60 000 VOLY
and €1.1 million VSL). While many experts in health impact
assessment (see Rabl et al, 2011) believe that the VSL is
poorly suited to the specific case of air pollution and the
underlying method for deriving life expectancy changes,
there remains support for its use. 
There are also some limitations to the analysis presented
here, principally in relation to the omission from the
monetised damage estimates of impacts on ecosystems,
and possibly the omission of effects of long-term exposure
to ozone on mortality. Inclusion of these impacts would
increase our estimates of co-benefits, noting in particular the
extensive exceedance of the critical load for nutrient
nitrogen. 
Nonetheless, it is clear that given the size of these co-
benefits, they warrant much greater consideration in the
discussion of mitigation policy than currently given. Further
work to monetise additional co-benefits, such as energy
security, are also highlighted as a priority.
Finally, despite the significant fall in emissions of the regional
pollutants under the Baseline, described above, and despite
the further reductions in emissions associated with the
Mitigation Scenario, there remains a loss of 905,000 million
life years annually across the EU27 by 2050. Along with the
still widespread exceedance of the critical load for
eutrophication by 2050, this demonstrates both the severity
of the problems of regional air pollution and the difficulties in
addressing them. This, in turn, emphasises the need to
exploit opportunities that exist in the synergies between
climate and air quality policies.
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Table A1. Country codes
AT Austria
BE Belgium
BG Bulgaria
CY Cyprus
CZ Czech Republic
DK Denmark
EE Estonia
FI Finland
FR France
DE Germany
GR Greece
HU Hungary
IE Ireland
IT Italy
LV Latvia
LT Lithuania
LU Luxembourg
MT Malta
NL Netherlands
PL Poland
PT Portugal
RO Romania
SK Slovakia
SI Slovenia
ES Spain
SE Sweden
UK United Kingdom
Air Quality
List of health impacts quantified
Impact / population group Population Exposure metric
Mortality from acute exposure All ages O3, SOMO35
Respiratory Hospital Admissions Over 65 years O3, SOMO35
Minor Restricted Activity Days (MRADs) 15 to 64 years O3, SOMO35
Respiratory medication use Adults over 20 years O3, SOMO35
Mortality from chronic exposure as life Over 30 years PM2.5, annual average
years lost or premature deaths
Infant Mortality 1 month to 1 year PM2.5, annual average
Chronic Bronchitis Over 27 years PM2.5, annual average
Respiratory Hospital Admissions All ages PM2.5, annual average
Cardiac Hospital Admissions All ages PM2.5, annual average
Restricted Activity Days (RADs) 15 to 64 years PM2.5, annual average
Respiratory medication use 5 to 14 years PM2.5, annual average
Respiratory medication use Over 20 years PM2.5, annual average
Lower Respiratory Symptom days 5 to 14 years PM2.5, annual average
Lower Respiratory Symptom days Over 15 years PM2.5, annual average
Note the effect of chronic exposure to PM2.5 on mortality is expressed in two ways, in terms of the loss of life expectancy
(expressed as the total number of life years lost annually across the affected population) and the number of deaths
brought forward (expressed as number of cases (deaths) per year). The loss of life expectancy is the preferred measure
of impact on theoretical and practical grounds, though deaths brought forward is included for valuation purposes. The
two estimates are not additive, however, they allow alternative valuation approaches to be adopted. 
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Table A2. Estimated average loss of life expectancy (Months) (Source GAINS, Rafaj et al, 2011).
Baseline Scenario Mitigation Scenario
Country 2005 2020 2030 2050 2020 2030 2050
Austria 6.7 3.2 2.6 2.6 3.0 2.1 1.6
Belgium 11.5 6.1 5.6 6.0 5.7 4.9 4.2
Bulgaria 8.2 3.4 3.0 3.2 3.1 2.1 1.5
Cyprus 4.1 4.1 3.9 4.4 3.2 2.1 1.5
Czech Rep. 8.2 4.1 3.3 3.3 3.9 2.7 2.0
Denmark 6.4 3.3 3.0 3.1 3.1 2.6 2.3
Estonia 5.2 2.8 2.5 2.6 2.5 2.0 1.6
Finland 2.9 1.6 1.5 1.7 1.5 1.2 1.0
France 6.9 3.5 2.9 2.9 3.3 2.5 2.0
Germany 8.7 4.4 3.8 3.9 4.1 3.2 2.5
Greece 7.8 3.7 3.0 3.2 3.4 2.3 1.9
Hungary 9.5 4.7 4.0 4.1 4.4 3.1 2.3
Ireland 3.4 1.8 1.5 1.5 1.8 1.3 1.1
Italy 6.6 3.4 2.5 2.7 3.2 2.1 1.7
Latvia 5.8 3.5 3.1 3.1 3.3 2.6 2.0
Lithuania 5.7 3.3 3.1 3.3 3.1 2.6 2.1
Luxembourg 8.6 4.4 3.9 4.2 4.2 3.4 2.9
Malta 5.1 3.9 2.1 2.1 3.8 1.8 1.6
Netherlands 11.1 5.8 5.4 5.8 5.5 4.7 4.2
Poland 9.0 4.6 3.7 3.7 4.3 3.1 2.3
Portugal 6.5 3.7 3.1 3.2 3.5 2.6 2.1
Romania 9.1 4.2 3.7 3.9 3.8 2.7 1.9
Slovakia 8.3 4.0 3.4 3.5 3.8 2.7 2.0
Slovenia 7.3 3.6 2.9 2.9 3.4 2.3 1.7
Spain 4.5 2.2 1.6 1.7 2.1 1.4 1.1
Sweden 3.4 1.8 1.7 1.8 1.7 1.5 1.3
United Kingdom 6.2 3.1 2.7 2.8 2.9 2.4 2.1
EU-27 average 7.3 3.7 3.1 3.1 3.5 2.6 2.0
Albania 5.0 2.4 1.9 2.1 2.3 1.5 1.2
Belarus 6.3 4.2 4.2 5.0 4.0 4.2 3.6
Bosnia-H 5.4 2.4 2.0 2.2 2.2 1.6 1.2
Croatia 7.5 3.8 3.0 3.2 3.5 2.3 1.8
FYR Macedonia 5.8 2.5 2.1 2.2 2.3 1.5 1.1
R Moldova 7.5 4.2 4.0 4.4 3.6 2.7 2.4
Norway 2.2 1.3 1.3 1.5 1.3 1.2 1.2
Russia 7.4 4.8 4.8 4.4 4.1
Serbia-M 7.5 3.2 2.7 3.0 2.9 2.0 1.4
Switzerland 5.4 2.7 2.2 2.4 2.6 1.9 1.6
Turkey
Ukraine 8.6 5.2 5.1 5.7 4.3 3.3 2.6
Non-EU average 7.3 4.5 4.4 4.1 4.1 3.6 2.1
Mitigatio  Scenario
Air Quality
Table A3. Health impacts (cases per year) for the EU27 of for the Baseline and the Mitigation Scenario for 2020, 2030 and
2050 (source ALPHA), and the Co-Benefits. 
Cases/year
Results for 2020
Baseline Mitigation Co-benefit
Acute mortality (all ages) deaths O3 19,911 19,455 456
Respiratory hospital admissions (65yr +) O3 19,610 19,173 437
Minor restricted activity days (15-64yr) O3 43,904,691 42,909,607 995,084
Respiratory medication use (adults 20yr +) O3 16,671,412 16,295,076 376,335
Chronic mortality, life years lost PM 1,793,840 1,684,260 109,580
Infant Mortality (1 month - 1yr) deaths PM 304 284 20
Chronic bronchitis (27yr +) new incidence PM 84,559 79,467 5,091
Respiratory hospital admissions (all ages) PM 32,370 30,425 1,945
Cardiac hospital admissions (all ages) PM 19,964 18,764 1,200
Restricted activity days (RADs 15-64yr) PM 165,076,033 155,113,567 9,962,466
Respiratory medication use (children 5-14yr) days PM 1,624,839 1,527,875 96,964
Respiratory medication use (adults 20yr +) days PM 15,139,994 14,228,761 911,234
Lower respiratory symptom days (children 5-14yr) PM 83,498,667 78,515,813 4,982,854
Lower respiratory symptom days (15yr +) PM 153,110,816 143,899,871 9,210,946
Results for 2030
Acute mortality (all ages) deaths O3 20,067 18,958 1,109
Respiratory hospital admissions (65yr +) O3 21,663 20,505 1,159
Minor restricted activity days (15-64yr) O3 39,396,060 37,257,639 2,138,421
Respiratory medication use (adults 20yr +) O3 15,952,748 15,090,715 862,033
Chronic mortality, life years lost PM 1,443,492 1,215,323 228,170
Infant Mortality (1 month - 1yr) deaths PM 223 186 37
Chronic bronchitis (27yr +) new incidence PM 72,204 60,925 11,279
Respiratory hospital admissions (all ages) PM 27,441 23,174 4,268
Cardiac hospital admissions (all ages) PM 16,924 14,292 2,632
Restricted activity days (RADs 15-64yr) PM 131,614,877 110,986,476 20,628,401
Respiratory medication use (children 5-14yr) days PM 1,352,598 1,144,796 207,802
Respiratory medication use (adults 20yr +) days PM 12,873,281 10,865,142 2,008,138
Lower respiratory symptom days (children 5-14yr) PM 69,508,511 58,829,817 10,678,694
Lower respiratory symptom days (15yr +) PM 130,378,109 110,050,954 20,327,155
Results for 2050
Acute mortality (all ages) deaths O3 24,259 20,884 3,374
Respiratory hospital admissions (65yr +) O3 27,869 24,075 3,794
Minor restricted activity days (15-64yr) O3 36,150,820 31,214,804 4,936,016
Respiratory medication use (adults 20yr +) O3 16,688,648 14,411,345 2,277,303
Chronic mortality, life years lost PM 1,387,251 904,805 482,446
Infant Mortality (1 month - 1yr) deaths PM 201 129 72
Chronic bronchitis (27yr +) new incidence PM 76,839 50,282 26,556
Respiratory hospital admissions (all ages) PM 28,933 18,968 9,965
Cardiac hospital admissions (all ages) PM 17,844 11,698 6,146
Restricted activity days (RADs 15-64yr) PM 124,127,047 81,419,761 42,707,287
Respiratory medication use (children 5-14yr) days PM 1,391,384 917,130 474,254
Respiratory medication use (adults 20yr +) days PM 13,643,560 8,933,242 4,710,318
Lower respiratory symptom days (children 5-14yr) PM 71,501,674 47,130,298 24,371,376
Lower respiratory symptom days (15yr +) PM 137,690,472 90,189,476 47,500,996
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Table A4. Monetised equivalent of health impacts for the EU27 of the Baseline and the Mitigation Scenario for 2020, 2030
and 2050, and Economic Co-benefits. All figures in €millions/year (current prices, undiscounted, VOLY estimates for
mortality risks). Source ALPHA.
€millions/year   
Results for 2020
Baseline Mitigation Co-benefit 
Acute mortality (all ages) deaths O3 1,195 1,167 27
Respiratory hospital admissions (65yr +) O3 45 44 1
Minor restricted activity days (15-64yr) O3 1,932 1,888 44
Respiratory medication use (adults 20yr +) O3 17 16 0
Chronic mortality, life years lost PM 107,630 101,056 6,575
Infant Mortality (1 month - 1yr) deaths PM 1,731 1,617 114
Chronic bronchitis (27yr +) new incidence PM 18,265 17,165 1,100
Respiratory hospital admissions (all ages) PM 74 70 4
Cardiac hospital admissions (all ages) PM 46 43 3
Restricted activity days (RADs 15-64yr) PM 15,847 14,891 956
Respiratory medication use (children 5-14yr) days PM 2 2 0
Respiratory medication use (adults 20yr +) days PM 15 14 1
Lower respiratory symptom days (children 5-14yr) PM 3,674 3,455 219
Lower respiratory symptom days (15yr +) PM 6,737 6,332 405
Total 157,209 147,759 9,450
Acute mortality (all ages) deaths O3 1,204 1,137 67
Respiratory hospital admissions (65yr +) O3 50 47 3
Minor restricted activity days (15-64yr) O3 1,733 1,639 94
Respiratory medication use (adults 20yr +) O3 16 15 1
Chronic mortality, life years lost PM 86,610 72,919 13,690
Infant Mortality (1 month - 1yr) deaths PM 1,272 1,060 212
Chronic bronchitis (27yr +) new incidence PM 15,596 13,160 2,436
Respiratory hospital admissions (all ages) PM 63 53 10
Cardiac hospital admissions (all ages) PM 39 33 6
Restricted activity days (RADs 15-64yr) PM 12,635 10,655 1,980
Respiratory medication use (children 5-14yr) days PM 1 1 0
Respiratory medication use (adults 20yr +) days PM 13 11 2
Lower respiratory symptom days (children 5-14yr) PM 3,058 2,589 470
Lower respiratory symptom days (15yr +) PM 5,737 4,842 894
Total 128,027 108,162 19,865
Acute mortality (all ages) deaths O3 1,456 1,253 202
Respiratory hospital admissions (65yr +) O3 64 55 9
Minor restricted activity days (15-64yr) O3 1,591 1,373 217
Respiratory medication use (adults 20yr +) O3 17 14 2
Chronic mortality, life years lost PM 83,235 54,288 28,947
Infant Mortality (1 month - 1yr) deaths PM 1,147 737 410
Chronic bronchitis (27yr +) new incidence PM 16,597 10,861 5,736
Respiratory hospital admissions (all ages) PM 67 44 23
Cardiac hospital admissions (all ages) PM 41 27 14
Restricted activity days (RADs 15-64yr) PM 11,916 7,816 4,100
Respiratory medication use (children 5-14yr) days PM 1 1 0
Respiratory medication use (adults 20yr +) days PM 14 9 5
Lower respiratory symptom days (children 5-14yr) PM 3,146 2,074 1,072
Lower respiratory symptom days (15yr +) PM 6,058 3,968 2,090
Total 125,350 82,521 42,828
Baseline Co-benefitMitigation
Results for 2030
Results for 2050
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